Department of Cardiovascular Medicine, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, #87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China.
Department of Gastroenterology and Endoscopy, Eastern Hepatobiliary Surgery Hospital, Naval Military Medical University, Shanghai, China.
Cardiovasc Diabetol. 2024 Jun 20;23(1):213. doi: 10.1186/s12933-024-02308-w.
The triglyceride glucose (TyG) index, TyG-body mass index (TyG-BMI), and triglyceride-density lipoprotein cholesterol ratio (TG/HDL-C) are substitute indicators for insulin resistance (IR). This study aimed to compare the predictive value of these indicators for 5-year mortality in critically ill patients with chronic heart failure (CHF).
Critically ill patients with CHF were identified from the Multiparameter Intelligent Monitoring in Intensive Care (MIMIC) III and IV databases. The primary outcome was 5-year mortality. The relationship between the three indices and mortality risk was determined using multivariate Cox proportional hazards models, Kaplan-Meier (K‒M) analysis and restricted cubic splines analysis. A receiver operating characteristic (ROC) curve was generated to compare the ability of the three indices to predict mortality. Finally, whether the IR indices would further increase the predictive ability of the basic model including baseline variables with a significance level between survivors and non-survivors was evaluated by ROC curve.
Altogether, 1329 patients with CHF were identified from the databases. Cox proportional hazards models indicated that the TyG index was independently associated with an elevated risk of 5-year mortality (hazard ratio [HR], 1.56; 95% confidence interval [CI] 1.29-1.9), while the TyG-BMI index and TG/HDL-C level were significantly associated with 5-year mortality, with an HR (95% CI) of 1.002 (1.000-1.003) and 1.01 (1.00-1.03), respectively. The K-M analysis revealed that the cumulative incidence of all-cause 5-year death increased with increasing quartiles of the TyG index, TyG-BMI index, or TG/HDL-C ratio. According to the ROC curve, the TyG index outperformed the TyG-BMI and TG/HDL-C ratio at predicting all-cause 5-year mortality (0.608 [0.571-0.645] vs. 0.558 [0.522-0.594] vs. 0.561 [0.524-0.598]). The effect of the TyG index on all-cause mortality was consistent across subgroups, with no significant interaction with randomized factors. Furthermore, adding the TyG index to the basic model for 5-year mortality improved its predictive ability (area under the curve, 0.762 for the basic model vs. 0.769 for the basic model + TyG index); however, the difference was not statistically significant.
As continuous variables, all three indices were significantly associated with 5-year mortality risk in critically ill patients with CHF. Although these IR indices did not improve the predictive power of the basic model in patients with CHF, the TyG index appears to be the most promising index (vs. TyG-BMI and TG/HDL-C ratio) for prevention and risk stratification in critically ill patients with CHF.
三酰甘油葡萄糖(TyG)指数、TyG-体重指数(TyG-BMI)和三酰甘油-高密度脂蛋白胆固醇比值(TG/HDL-C)是胰岛素抵抗(IR)的替代指标。本研究旨在比较这些指标对慢性心力衰竭(CHF)危重症患者 5 年死亡率的预测价值。
从 Multiparameter Intelligent Monitoring in Intensive Care(MIMIC)III 和 IV 数据库中确定患有 CHF 的危重症患者。主要结局为 5 年死亡率。使用多变量 Cox 比例风险模型、Kaplan-Meier(K-M)分析和限制性立方样条分析确定三个指标与死亡率风险之间的关系。绘制受试者工作特征(ROC)曲线以比较三个指标预测死亡率的能力。最后,通过 ROC 曲线评估 IR 指标是否会进一步增加基本模型的预测能力,基本模型包括幸存者和非幸存者之间有统计学意义的基线变量。
从数据库中总共确定了 1329 例 CHF 患者。Cox 比例风险模型表明,TyG 指数与 5 年死亡率升高独立相关(危险比 [HR],1.56;95%置信区间 [CI],1.29-1.9),而 TyG-BMI 指数和 TG/HDL-C 水平与 5 年死亡率显著相关,HR(95%CI)分别为 1.002(1.000-1.003)和 1.01(1.00-1.03)。K-M 分析显示,所有原因的 5 年累计死亡率随 TyG 指数、TyG-BMI 指数或 TG/HDL-C 比值的四分位数升高而增加。根据 ROC 曲线,TyG 指数在预测全因 5 年死亡率方面优于 TyG-BMI 和 TG/HDL-C 比值(0.608[0.571-0.645]vs.0.558[0.522-0.594]vs.0.561[0.524-0.598])。TyG 指数对全因死亡率的影响在各亚组中一致,与随机因素无显著交互作用。此外,将 TyG 指数添加到基本模型中可提高 5 年死亡率的预测能力(基本模型的曲线下面积为 0.762,基本模型+TyG 指数为 0.769);然而,差异无统计学意义。
作为连续变量,所有三个指标均与 CHF 危重症患者 5 年死亡风险显著相关。尽管这些 IR 指标并未提高 CHF 患者基本模型的预测能力,但 TyG 指数似乎是 CHF 危重症患者预防和风险分层最有前途的指标(优于 TyG-BMI 和 TG/HDL-C 比值)。